Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abducens nerve paralysis
acute disseminated encephalomyelitis
acute disseminated encephalomyelitis, multiphasic
adenylate kinase 5 autoantibodies
advances in neurology
afebrile
affect, flat
aggression
agitation
alternative medicine
alveolar hypoventilation
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, preclinical
amnesia
amnesia, anterograde
amygdala
amygdalohippocampectomy
amyloid beta protein
amyloid imaging
amyloid plaques
ANA
angiography, cerebral
anti Hu antibody
anti Ro antibody
anticonvulsants
anticonvulsants, effectiveness
anticonvulsants, selection of
anticonvulsants, untoward effects of
antiviral agents
anxiety
aphasia
apolipoprotein E
arrhythmia, cardiac
arteriovenous malformation
arteriovenous malformation, cerebral
astrocytoma
asymptomatic
ataxia
ataxia, cerebellar
atypical
aura
autism
autoantibodies
autoimmune cerebellar ataxia
autoimmune disease
autoimmune GFAP astrocytopathy
automatisms
autonomic dysfunction
B cell lymphoma
Babinski sign
barbiturate anesthesia
basal ganglia
basal ganglia, lesion of
behavior
behavior, combative
behavioral disorder
biologic markers
blindness
blindness, sudden
brain atrophy
brain biopsy
brain volume
brainstem, lesion of
burst suppression pattern, electroencephalogram
carcinoma
carcinoma of lung
CAT scan
CAT scan, abnormal
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, false negative
CAT scan, metrizamide
cavernous hemangioma
CD19-directed chimeric antigen receptor T-cell therapy
central nervous system, infection of
cerebellar lesion
cerebellar pontine angle
cerebellar pontine angle tumor
cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy
cerebral cortex
cerebral cortical atrophy
cerebral edema
cerebral edema, vasogenic
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, oligoclonal IgG in
chemotherapy, CNS treatment and complications with
children
Clinical Pathologic Conference(C.P.C.)
cognition
coma
coma, medically induced
complications
confusion
confusional state, acute
corpus callosotomy
corpus callosum
corpus callosum, lesion of
cortical dysplasia, focal
cortical resection
cost effectiveness
cytokine release syndrome
cytomegalovirus infection
deep gray nuclei
degenerative diseases of CNS
delusion
dementia
dementia, diagnostic evaluation of
dementia, early detection
dementia, frontotemporal
dementia, rapidly progressive
dementia, screening for
demyelinating disease
diagnostic criteria
diarrhea
diet
differential diagnosis
diplopia
disability, neurological
disorientation
drowsiness
dysarthria
dyskinesia
dyskinesia, buccal lingual facial
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electroencephalogram, periodic complexes
electroencephalogram, video monitoring with
encephalitis
encephalitis, autoimmune
encephalitis, focal
encephalitis, unknown etiology
encephalitis, viral
encephalomalacia
encephalomyelitis
encephalopathy
encephalopathy, acute
encephalopathy, limbic
encephalopathy, post traumatic
epilepsy
epilepsy monitoring unit
epileptic encephalopathy
episodic disorders
episodic neurologic deficits
eye movement, disorders of
face, numbness of
facial asymmetry
facial weakness
familial
febrile infection-related epilepsy syndrome
fever
flu-like illness
gammaglobulin therapy, intravenous
gender
Geschwind, Norman
GFAP-IgG
glioma
gliomatosis cerebri
gliosis
glutamic acid decarboxylase, antibody
glyphosate
gray matter
hallucination
hallucination, auditory
hamartoma
head injury
head injury, prognosis in
headache
headache, recurrent
hemimyoclonic jerks
hemiparesis
hemispherectomy
heralding manifestation
herbicide
herpes simplex encephalitis
hiccoughs
hippocampal atrophy
hippocampus
hippocampus, hyperintense
histopathology
human herpesvirus 6
hyperactivity
hypersomnia
hyponatremia
hypothalamus, lesion of
hypothyroidism
immune effector cell-associated neurotoxicity syndrome
immune-related adverse events
immunohistochemistry
immunologic disease
immunosuppression
immunosuppressive agents
immunotherapy
inattention
incidentaloma
inclusion bodies
inclusion bodies, intracytopasmic
infection
insular cortex
insular cortex, lesion
insular cortex, lesion, bilateral
intellectual deficit
intellectual deterioration
ketogenic diet
learning disability
learning disability, in children
lethargy
leucine rich glioma inactivated 1 antibodies
leukopenia
level of consciousness
level of consciousness, decreased
limbic encephalitis
limbic system
limbic-predominant age-related TDP-43 encephalopathy
lobar atrophy
lymphadenopathy, hilar
lymphoma
lymphoma, systemic
malformation, vascular
malformation, vascular, cerebral
malignancy screen
memory, defect of recent
memory, evaluation of
memory, impairment of
meningeal enhancement
meningioma
meningitis
meningitis, neurologic aspects and complications of
meningitis, seizures with
meningoencephalomyelitis
mental retardation
mesial temporal lobe
mesial temporal lobe epilepsy
mesial temporal sclerosis
mesial temporal sclerosis, bilateral
microhemorrhage, intracerebral
microinfarcts
midbrain, lesion of
middle cerebellar peduncle, lesion
mild cognitive impairment
mimics
misdiagnosis
mitochondrial disease
mortality
movement disorder
MRI
MRI pattern
MRI, abnormal
MRI, abnormal, seizure causing
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, disappearing lesion on
MRI, false negative
MRI, field strength, high
MRI, FLAIR
MRI, functional
MRI, gyral enhancement
MRI, head injury
MRI, incidental finding
MRI, indications for
MRI, morphometyry
MRI, negative
MRI, ring sign
MRI, ring sign, open
MRI, serial
MRI, spinal cord
MRI, volumetry
MRI, voxel-based morphometry
MRS
multiple sclerosis
multiple sclerosis, misdiagnosis
multiple subpial transection
myelitis, longitudinal
myoclonic jerks
myoclonus
negative
neoplasm, primary intracerebral
neoplasm, primary intracranial
neoplasm, primary of CNS
neoplasm, primary of CNS-children
neurologic disease, diagnoses of
neuromyelitis optica (Devic's disease)
neuromyelitis optica spectrum disorder
neuronal migration disorder
neuropathology
neuropathology, brain
neuropathy
neurosyphilis
neurotoxin
NMDA antagonists
NMDA receptors
normal
nystagmus
nystagmus, primary position of gaze
ocular dipping
old age, neurology of
optic chiasm
optic chiasm, lesion of
pain
pain, leg
pallor
paranoia
Parkinsonism syndrome
periaqueductal lesion
perseveration
personality change
personality disorder
plasmapheresis
PLEDs
PLEDs, bilateral independent
PLEDs, etiology of
pleocytosis of cerebrospinal fluid
posterior fossa, lesion of
postictal neurologic deficits
postictal psychosis
potassium channel antibodies
precipitating factors
preclinical
prevention of neurologic disorders
prognosis
progressive neurologic disorder
prosopagnosia
psychiatric problems in neurologic disorders
psychological testing
psychosis
psychosurgery
psychotic behavior
pulmonary nodules
quadrantanopsia, superior
quadriparesis
rapidly progressing neurologic illness
recurrent
release phenomena
religiosity
remote effect of cancer on the nervous system
reversible neurologic disorder
review article
rheumatoid arthritis factor(R.A.factor)
risk factors
salivation, excessive
schizophrenia
screening
sedimentation rate, elevated
seizure
seizure, adult onset
seizure, children
seizure, classification of
seizure, complications following
seizure, diagnosis of
seizure, drug resistance
seizure, elderly
seizure, equivalents
seizure, etiology of
seizure, febrile
seizure, febrile, risk of epilepsy following
seizure, focal
seizure, focus
seizure, intractable
seizure, intractable, treatment of
seizure, medication failure
seizure, new onset
seizure, prevention of
seizure, prognosis in adults
seizure, prognosis in childhood
seizure, psychomotor-frontal lobe
seizure, psychomotor-temporal lobe
seizure, psychomotor-temporal lobe, interictal behavior
seizure, psychomotor-temporal lobe, prognosis of
seizure, psychosocial aspects of
seizure, recurrent
seizure, risk factors for
seizure, surgical treatment of
seizure, treatment of
seizure, treatment of, polytherapy
seizure, treatment, adjunctive therapy
seizure, workup of
serologic testing
serologic testing of cerebrospinal fluid
seronegative
sexual behavior, disorder of
single photon emission computed tomography
Sjogren's syndrome
Sjogren's syndrome, neurologic manifestations of
sleep
small vessel disease
speech disorder
speech, slowed
standing difficulty
stare
status epilepticus
status epilepticus, intractable
steroid therapy, CNS treatment and complications with
stimulation, deep brain
subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease
subacute sclerosing panencephalitis, adult onset
subinsular cortex
symmetric brain lesions
syphilis, diagnosis and treatment
syphilis, neurologic complications with
tau protein
TDP-43 proteinopathy
temporal horn, enlarged
temporal lobe
temporal lobe, atrophy
temporal lobe, lesion
temporal lobe, lesion, bilateral
temporal lobe, status
temporal lobe, tumor
temporal lobectomy
temporal lobectomy, complications
teratoma
teratoma, ovarian
thalamus, lesion of
thyroid function tests
thyroiditis
tonic spasms
toxic encephalopathy
transient neurologic deficit
treatment of neurologic disorder
tremor
tuberous sclerosis
vaccination, neurologic complications with
vagus nerve stimulation
vasculopathy
ventricular enlargement
violent behavior
viral infection, CNS
visual field defect
visual loss
visual loss, sudden
water channel antibodies
weight loss
whistling
white matter disease
word-finding difficulty
workup
Showing articles 700 to 750 of 2500 << Previous Next >>

Primary Central Nervous System Vasculitis: Analysis of 101 Patients
Ann Neurol 62:442-451,430, Salvarani,C.,et al, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Neurologic Complications of Gastric Bypass Surgery for Morbid Obesity
Neurol 68:1843-1850, Juhasz-Pocsine,K.,et al, 2007

Orthostatic Myoclonus: A Contributor to Gait Decline in Selected Elderly
Neurol 68:1826-1830, Glass,G.A.,et al, 2007

Mitoxantrone for Multiple Sclerosis Causing Acute Lymphoblastic Leukemia
Neurol 68:1630-1631, Cartwright,M.S.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Electromyographic Biofeedback for the Recovery of Motor Function After Stroke
Stroke 38:1999-2000, Woodford,H.J. &Price,C., 2007

Amyotrophic Lateral Sclerosis
Lancet 369:2031-2041, Mitchell,J.D. & Borasio,G.D., 2007

Natural History of Multiple Sclerosis with Childhood Onset
NEJM 356:2603-2613, Renoux,C.,et al, 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Neuropsychiatric Syndromes Associated With Multiple Sclerosis
J Neurol 254:II/73-II/76, Feinstein,A., 2007

Palliative Care for Patients With Amyotrophic Lateral Sclerosis
JAMA 298:207-216,248, Mitsumoto,H. &Rabkin,J.G., 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy Syndrome
AJNR 28:1320-1327, Bartynski,W.S.,et al, 2007

Effect of Early Verus Delayed Interferon Beta-1b Treatment on Disability After a First Clinical Event Suggestive of Multiple Sclerosis: A 3-Year Follow-Up Analysis of the BENEFIT Study
Lancet 370:389-397, Kappos,L.,et al, 2007

What Do We Really See When We Look at Magnetic Resonance Images?
Ann Neurol 62:207-208, Filippi,M. &Hartung,H.-P., 2007

Rehabilitation for Spatial Neglect Improves Test Performance But Not Disability
Stroke 38:2869-2870, Bowen,A. &Lincoln,N.B., 2007

Treatment of Physicians With Epilepsy
Neurol 69:1374-1379, Allen,J.W. &Devinsky,O., 2007

Parental Transmission of MS in a Population-Based Canadian Cohort
Neurol 69:1208-1212,1202, Herrera,B.M.,et al, 2007

Thalamic Atrophy and Cognition in Multiple Sclerosis
Neurol 69:1213-1223, Houtchens,M.K.,et al, 2007

The Differential Diagnosis of Multiple Sclerosis
Neurologist 13:57-72, Rolak, L.A.,et al, 2007

Non-Herpetic Acute Limbic Encephalitis-like Manifestation in a Case of Hashimotos Encephalopathy with Positive Autoantibodies against Ionotropic Glutamate Receptor Epsilon
Rinsho Shinkeigaku 47:629-634, Shindo, A.,et al, 2007

Community-Acquired Bacterial Meningitis in Adults
NEJM 354:44-53, van de Beek,D.,et al, 2006

Premenstrual Multiple Sclerosis Pseudoexacerbations: Role of Body Temperature and Prevention With Aspirin
Arch Neurol 63:1005-1008, Wingerchuk,D.M. &Rodriguez,M., 2006

Significance of T2 Lesions in Multiple Sclerosis: A 13-Year Longitudinal Study
Ann Neurol 60:236-242, Rudick,R.A.,et al, 2006

Interferon beta-1a Treatment in Childhood and Juvenile-Onset Multiple Sclerosis
Neurol 67:511-513, Tenembaum,S.N. &Segura,M.J., 2006

Obsessive-Compulsive Disorder
BMJ 333:424-429, Heyman,I.,et al, 2006

Does High-Field MR Imaging Have an Influence on the Classification of Patients with Clinically Isolated Syndromes According to Current Diagnostic MR Imaging Criteria for Multiple Sclerosis
AJNR 27:1794-1798, Wattjes,M.P.,et al, 2006

Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
NEJM 355:1124-1140, Kappos,L.,et al, 2006

Baseline MRI Predicts Future Attacks and Disability in Clinically Isolated Syndromes
Neurol 67:968-972, Tintore,M.,et al, 2006

Multiple Sclerosis with and without CSF Bands:Clinically Indistinguishable but Immunogenetically Distinct
Neurol 67:1062-1064, Imrell,K.,et al, 2006

The Tuberous Sclerosis Complex
NEJM 355:1345-1356, Crino,P.B.,et al, 2006

In Vivo Detection of Cortical Plaques by MR Imaging in Patients with Multiple Sclerosis
AJNR 27:2161-2167, Bagnato,F.,et al, 2006

Pathologic Laughing and Intractable Hiccups Can Occur Early in Multiple Sclerosis
Neurol 67:1684-1686, de Seze,J.,et al, 2006

High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Arch Neurol 63:1388-1393, Gladstone,D.E.,et al, 2006

Neuromyelitis Optica IgG Status in Acute Partial Transverse Myelitis
Arch Neurol 63:1398-1400, Scott,T.F.,et al, 2006

Treatment With Interferon beta-1b Delays Conversion to Clinically Definite and McDonald MS in Patients With Clinically Isolated Syndromes
Neurol 67:1242-1249, Kappos,L.,et al, 2006

Infusion-Related Hypersensitivity Reactions During Natalizumab Treatment
Neurol 67:1717-1718, Phillips,J.T.,et al, 2006

Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
JAMA 296:2832-2838, Munger,K.L.,et al, 2006

Multiple Sclerosis in Twins From Continental Italy and Sardinia: A Nationwide Study
Ann Neurol 59:27-34, Ristori,G.,et al, 2006

Standardized MR Imaging Protocol for Multiple Sclerosis:Consortium of MS Centers Consensus Guidelines
AJNR 27:455-461, Simon,J.H.,et al, 2006

Safety and Tolerability of Interferon Beta-1b in Pediatric Multiple Sclerosis
Neurol 66:472-476, Banwell,B.,et al, 2006

Clinically Isolated Syndromes, A New Oligoclonal Band Test Accurately Predicts Conversion to MS
Neurol 66:576-578, Masjuan,J.,et al, 2006

Metabolic Disease and Stroke: MELAS
emedicine.com, Mandava,P.,et al, 2006

What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006

Multiple Sclerosis - The Plaque and Its Pathogenesis
NEJM 354:942-955, Frohman,E.M.,et al, 2006

Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006

The Natural History of Primary Lateral Sclerosis
Neurol 66:647-653, Gordon,P.H.,et al, 2006



Showing articles 700 to 750 of 2500 << Previous Next >>